Market watchers are increasingly focused on OPKO Health Inc. (OPK), a diversified healthcare company with a growing pipeline of innovative therapies and diagnostics. Recent strategic moves, clinical progress, and financial discipline highlight OPKO's potential as a stock to watch heading into 2026.
Strategic Collaboration with Regeneron
OPKO's subsidiary ModeX entered into a high-value research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. The partnership leverages ModeX's MSTAR technology platform alongside Regeneron's proprietary binders to create single-molecule candidates targeting multiple biological pathways.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.